BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23970381)

  • 21. What's New in Prevention of Invasive Fungal Diseases during Hospital Construction and Renovation Work: An Overview.
    Mareković I
    J Fungi (Basel); 2023 Jan; 9(2):. PubMed ID: 36836266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.
    Commission for Hospital Hygiene and Infection Prevention (KRINKO)
    GMS Hyg Infect Control; 2022; 17():Doc07. PubMed ID: 35707229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community Airborne Mold Spore Counts and Invasive Fungal Disease Risk Among Pediatric Hematological Malignancy and Stem Cell Transplant Patients.
    Almatrafi MA; Aquino VM; Slone T; Huang R; Sebert M
    Open Forum Infect Dis; 2021 Nov; 8(11):ofab481. PubMed ID: 34805427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Not Available].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Feb; 64(2):232-264. PubMed ID: 33394069
    [No Abstract]   [Full Text] [Related]  

  • 25. Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks.
    Benedict K; Richardson M; Vallabhaneni S; Jackson BR; Chiller T
    Lancet Infect Dis; 2017 Dec; 17(12):e403-e411. PubMed ID: 28774697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogens of infections in the induction period of childhood acute lymphoblastic leukemia and drug resistance of isolated strains].
    Chen ZS; Zheng L; Chen YQ; Yang JH; Li J
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Feb; 19(2):176-181. PubMed ID: 28202116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection Prevention in Transplantation.
    Pergam SA
    Curr Infect Dis Rep; 2016 Jan; 18(2):7. PubMed ID: 26820654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mold contamination in a controlled hospital environment: a 3-year surveillance in southern Italy.
    Caggiano G; Napoli C; Coretti C; Lovero G; Scarafile G; De Giglio O; Montagna MT
    BMC Infect Dis; 2014 Nov; 14():595. PubMed ID: 25398412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fungal diagnostic testing and therapy: navigating the neutropenic period in children with high-risk leukemia.
    Fisher BT
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):361-367. PubMed ID: 34889439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary aspergillosis in the neutropenic patient. Apropos of 4 cases].
    Ben Othman T; Ben Lakhal B; Medini Manai Z; Ladeb S; M'Sadek F; Meddeb B; Ben Abid H; Bel Hadj Ali Z; Hafsia R; Ben Abdeladhim A; Hafsia A
    Tunis Med; 1996 Nov; 74(11):493-500. PubMed ID: 9506113
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia.
    Pokala HR; Leonard D; Cox J; Metcalf P; McClay J; Siegel J; Winick N
    Pediatr Blood Cancer; 2014 Feb; 61(2):276-80. PubMed ID: 23970381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
    Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.
    Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ
    J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).
    Caira M; Candoni A; Verga L; Busca A; Delia M; Nosari A; Caramatti C; Castagnola C; Cattaneo C; Fanci R; Chierichini A; Melillo L; Mitra ME; Picardi M; Potenza L; Salutari P; Vianelli N; Facchini L; Cesarini M; De Paolis MR; Di Blasi R; Farina F; Venditti A; Ferrari A; Garzia M; Gasbarrino C; Invernizzi R; Lessi F; Manna A; Martino B; Nadali G; Offidani M; Paris L; Pavone V; Rossi G; Spadea A; Specchia G; Trecarichi EM; Vacca A; Cesaro S; Perriello V; Aversa F; Tumbarello M; Pagano L;
    Haematologica; 2015 Feb; 100(2):284-92. PubMed ID: 25638805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study.
    Even C; Bastuji-Garin S; Hicheri Y; Pautas C; Botterel F; Maury S; Cabanne L; Bretagne S; Cordonnier C
    Haematologica; 2011 Feb; 96(2):337-41. PubMed ID: 21071502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
    Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
    Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.